侵袭性真菌感染IFI的诊疗进展.pptVIP

* Mora-Duarte J et al. Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis. N Engl J Med 2002; 347: 2020-2029. Maertens J. Caspofungin: an advanced treatment approach for suspected or confirmed invasive aspergillosis [J ]. Int J Antimicrob Agents, 2006, 27 (6): 457-467. Aimee K. Zaas, et al. Caspofungin for Invasive Candidiasis at a Tertiary Care Medical Center. The American Journal of Medicine, 2006，119（11）：993.e1-993.e6 * a No activity against mucorales. b Infusion-related toxicity (fever, chills, hypoxia). c Failed the 10% noninferiority cut-off when compared with AmB (and